WaPo columnist & CMS official give dueling narratives of ChatGPT Health

The main question about health bots is accuracy and the trust or distrust that it engenders among users as a result. One journalist from the Washington Post and a strategic advisor to CMS had wildly differing experiences.

Editor's Pick

Top Story WaPo Columnist and CMS Official Provide Dueling Narratives of ChatGPT Health The main question about health bots is accuracy and the trust or distrust that it engenders among users as a result. One journalist from the Washington Post and a strategic advisor to CMS had wildly differing experiences. Sponsored Enhance Patient Care Through Intelligent Communication Presented by RingCentral Calling a hospital or medical practice can be a stressful, frustrating experience. RingCentral seeks to make the patient experience as frictionless and efficient as possible. Click here to learn how.

Featured News

The Growing Cost of Medical Bill Collection: How Healthcare Organizations Are Using New AI and Clinical Insights to Improve the Revenue Cycle Management Experience [Sponsored] A webinar sponsored by Smarter Technologies and moderated by MedCity News Editor-in-Chief Arundhati Parmar included insights on the user experience and benefits from Lakeland Regional Health. NOCD Launches Parent Brand Noto, Acquires PTSD Provider Rebound Health NOCD launched a new parent brand, Noto, and acquired PTSD provider Rebound Health to expand its virtual, specialty therapy model beyond OCD into other complex mental health conditions. Climatic Emerges from Stealth With $10M to Build a Daily Lung Health Category Climatic, a new wellness startup, emerged from stealth with a $10 million seed round for the non-prescription inhalant it's developing, which is designed to support daily lung health. The company aims to create a new category of preventive lung care, mainly for athletes and health-conscious consumers. With CMS's New List of Meds for Drug Price Negotiation, Analyst Sees Small Financial Hit to Pharmas The 15 drugs selected for the Centers for Medicare and Medicaid Services drug price negotiation program accounted for about $27 billion in total prescription spending under Medicare Parts B and D. But this revenue from Medicare makes up a small percentage of each drug manufacturer's total sales. WaPo Columnist and CMS Official Provide Dueling Narratives of ChatGPT Health The main question about health bots is accuracy and the trust or distrust that it engenders among users as a result. One journalist from the Washington Post and a strategic advisor to CMS had wildly differing experiences. Harnessing RWE for Post-Pandemic Healthcare: Accelerating Drug Development with Real-World Data As RWE continues to influence the future of drug development, pharma companies will inevitably encounter hurdles. But with the right approach, they can be overcome to unlock critical insights and bring better therapies to patients faster.  Rethinking Security Among the Healthcare Workforce Crisis As hospitals adapt to a landscape marked by staffing shortages, financial pressure and escalating safety concerns, security can no longer operate as an afterthought or a cost center. It must be a strategic enabler that protects the workforce, which in turn protects everyone else.

Video   Video: Inside a New Recursion Drug Katie Couric lost her husband to colon cancer in 1998. Nearly 30 years later, colon cancer rates are rising sharply, especially among younger people, and scientists still don't fully understand why. Watch Couric chat with Najat Khan, CEO of Recursion Pharmaceuticals. Recursion is using AI to identify a promising compound that targets the underlying biology of the disease.

Sponsored Omaha ABA Therapy: Comparing the Top Providers Presented by Stride Autism Centers The right provider enables children to gain confidence, learn to express their needs and discover new ways to connect with the world around them. Learn More

Resources

sponsored Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health Presented by Esperion In a recent interview, Esperion President and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company's expansion into new diseases. Read more

MedCity News • PO Box 901 • New York, NY unsubscribe